Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.

about

Purinergic Signalling: Therapeutic Developments.PlanHab Study: Consequences of combined normobaric hypoxia and bed rest on adenosine kinetics.

P2860

Q42367885-B5CB3E73-5CBA-40D8-9FCD-450DA1AD1639 Q48043299-E4304C70-BF1A-4165-B189-19A339AEB8A0

P2860

Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.

Item

http://www.wikidata.org/entity/Q41694800

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Development of a novel strateg ...... y ischemia-reperfusion injury.

@en

type

Item

label

Development of a novel strateg ...... y ischemia-reperfusion injury.

@en

prefLabel

Development of a novel strateg ...... y ischemia-reperfusion injury.

@en

P1476

Development of a novel strateg ...... y ischemia-reperfusion injury.

@en

P2093

Bo Lu

http://www.w3.org/2001/XMLSchema#string

Carly Selan

http://www.w3.org/2001/XMLSchema#string

Karen M Dwyer

http://www.w3.org/2001/XMLSchema#string

Peter J Cowan

http://www.w3.org/2001/XMLSchema#string

Sandra Crikis

http://www.w3.org/2001/XMLSchema#string

Shala Dezfouli

http://www.w3.org/2001/XMLSchema#string

Simon C Robson

http://www.w3.org/2001/XMLSchema#string

Yuping Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of CD39/vascular ATP diphosphohydrolase

Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain

5'-Nucleotidase: molecular structure and functional aspects

5′-Nucleotidase: molecular structure and functional aspects

Bleeding time in laboratory animals. III - Do tail bleeding times in rats only measure a platelet defect? (the aspirin puzzle).

Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.

The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction.

Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin.

Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection

Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?

P2888

s11302-017-9558-3

P304

259-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11302-017-9558-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Harshal H. Nandurkar

Karlheinz Peter

Michael J Hickey

Maithili Sashindranath

P577

2017-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28343356

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

reperfusion injury

P932

5432485

http://www.w3.org/2001/XMLSchema#string

Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.

about

P2860

P2860

Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932